In the central nervous system, glycine is a co-agonist with glutamate at the N-methyl-D-aspartate subtype of glutamate receptors and also an agonist at inhibitory, strychnine-sensitive glycine receptors. The GLYT1 subtypes of glycine transporters (GLYTs) are responsible for regulation of glycine at excitatory synapses, whereas a combination of GLYT1 and GLYT2 subtypes of glycine transporters are used at inhibitory glycinergic synapses. Zn 2؉ is stored in synaptic vesicles with glutamate in a number of regions of the brain and is believed to play a role in modulation of excitatory neurotransmission. In this study we have investigated the actions of Zn 2؉ on the glycine transporters, GLYT1b and GLYT2a, expressed in Xenopus laevis oocytes and we demonstrate that Zn 2؉ is a noncompetitive inhibitor of GLYT1 but has no effect on GLYT2. We have also investigated the molecular basis for these differences and the relationship between the Zn 2؉ and proton binding sites on GLYT1. Using site-directed mutagenesis, we identified 2 histidine residues, His-243 in the large second extracellular loop (ECL2) and His-410 in the fourth extracellular loop (ECL4), as two coordinates in the Zn 2؉ binding site of GLYT1b. In addition, our study suggests that the molecular determinants of proton regulation of GLYT1b are localized to the 2 histidine residues (His-410 and His-421) of ECL4. The ability of Zn 2؉ and protons to regulate the rate of glycine transport by interacting with residues situated in ECL4 of GLYT1b suggests that this region may influence the substrate translocation mechanism.
In the central nervous system, glycine is a co-agonist with glutamate at the N-methyl-D-aspartate subtype of glutamate receptors and also an agonist at inhibitory, strychnine-sensitive glycine receptors. The GLYT1 subtypes of glycine transporters (GLYTs) are responsible for regulation of glycine at excitatory synapses, whereas a combination of GLYT1 and GLYT2 subtypes of glycine transporters are used at inhibitory glycinergic synapses. Zn 2؉ is stored in synaptic vesicles with glutamate in a number of regions of the brain and is believed to play a role in modulation of excitatory neurotransmission. In this study we have investigated the actions of Zn 2؉ on the glycine transporters, GLYT1b and GLYT2a, expressed in Xenopus laevis oocytes and we demonstrate that Zn 2؉ is a noncompetitive inhibitor of GLYT1 but has no effect on GLYT2. We have also investigated the molecular basis for these differences and the relationship between the Zn 2؉ and proton binding sites on GLYT1. Using site-directed mutagenesis, we identified 2 histidine residues, His-243 in the large second extracellular loop (ECL2) and His-410 in the fourth extracellular loop (ECL4), as two coordinates in the Zn 2؉ binding site of GLYT1b. In addition, our study suggests that the molecular determinants of proton regulation of GLYT1b are localized to the 2 histidine residues (His-410 and His-421) of ECL4. The ability of Zn 2؉ and protons to regulate the rate of glycine transport by interacting with residues situated in ECL4 of GLYT1b suggests that this region may influence the substrate translocation mechanism.
The amino acid glycine is a co-agonist with glutamate at the N-methyl-D-aspartate (NMDA) 1 subtype of glutamate receptors (1) and also an agonist at inhibitory, strychnine-sensitive, glycine receptors (2) . Glycine transporters (GLYTs), which regulate synaptic glycine concentrations, belong to the Na ϩ -and Cl Ϫ -dependent neurotransmitter transporter family that includes the transporters for ␥-aminobutyric acid (GABA) (GAT), dopamine (DAT), norepinephrine (NET), and serotonin (SERT) (3) . These membrane proteins share a common structure of 12 transmembrane domains (TMs) with amino-and carboxyl-terminal ends oriented intracellularly. Two high affinity glycine transporters, both with several alternative isoforms, have been identified (4 -10) . The GLYT1 subtypes are expressed in glial cells throughout the brain and spinal cord in close proximity to both excitatory glutamatergic synapses and inhibitory glycinergic synapses, whereas the GLYT2 subtypes are expressed in inhibitory glycinergic neurons of the spinal cord and brain stem (11) . It has been suggested that the GLYT1 subtypes are responsible for regulation of glycine at excitatory synapses, whereas a combination of GLYT1 and GLYT2 subtypes are used at inhibitory glycinergic synapses (7, (12) (13) (14) (15) .
The stoichiometry of ion flux coupling for GLYT1 is 2 Na ϩ and 1 Cl Ϫ transport for each molecule of glycine, and from this it may be predicted that under physiological conditions GLYT1 will maintain extracellular glycine concentrations at ϳ150 nM (16, 17) . The concentration of glycine required to activate NMDA receptors varies within the range of 0.1-3 M, depending on the NMDA receptor subtype (18) , and therefore the equilibrium glycine concentration maintained by GLYT1 transporters falls within the dynamic response range for activation of NMDA receptors. Thus, modulation of glycine transporter activity has the capacity to influence the extent of glycine occupancy of NMDA receptors and provide an alternate mechanism for modulation of NMDA-mediated excitatory neurotransmission (12) .
NMDA receptors and the GLYT1 subtype of glycine transporters are both modulated by a number of endogenous compounds, including arachidonic acid (19) , anandamide (19) , and protons (20) . Zn 2ϩ is widely distributed in the central nervous system, with chelatable Zn 2ϩ being abundant in particular regions of the brain, including excitatory terminals of the mossy fibers of the hippocampus. In this region, Zn 2ϩ is colocalized in synaptic vesicles with glutamate and is released into the synaptic cleft during neurotransmission, reaching concentrations up to 300 M (21-24). It has been shown that micromolar concentrations of Zn 2ϩ can modulate the activity of a number of proteins within excitatory synapses, including NMDA receptors (25, 26) , Ca 2ϩ channels (27) , and glutamate transporters (28 -30) . Moreover, it has recently been reported that low concentrations of Zn 2ϩ (5 M) impaired glycine transport by the heterologously expressed GLYT1 (31) . In this study we have further investigated the actions of Zn 2ϩ on the glycine transporters, GLYT1b and GLYT2a, expressed in Xenopus laevis oocytes and demonstrate that Zn 2ϩ is a noncompetitive inhibitor of GLYT1 but has no effect on GLYT2. We have also investigated the molecular basis for these differences and the relationship between the Zn 2ϩ and proton binding sites on GLYT1. This study expands the number of endogenous com-* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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pounds that show coordinated modulation of receptors, ion channels, and transporters within excitatory synapses.
EXPERIMENTAL PROCEDURES
Chemicals-All chemicals were obtained from Sigma (Sydney, Australia) unless otherwise stated. [2-(Trimethylammonium)ethyl]methanethiosulfonate (MTSET) and 2-sulfonatoethylmethanethiosulfonate (MTSES) were obtained from Toronto Research Chemicals (Toronto, Canada). Zinc chloride was diluted from a stock solution of 20 mM in frog Ringer's solution. The stock solution was stored at 4°C and was made up fresh each week.
Expression of Transporters in X. laevis Oocytes and Electrophysiological Recordings-cDNAs encoding the human glycine transporter GLYT1b were subcloned into the pOTV plasmid. The wild type and mutant GLYT1b transporters were linearized with SpeI and cRNA transcribed from the cDNA construct with T7 RNA polymerase and capped with 5Ј-7-methyl guanosine using the mMessage mMachine kit (Ambion Inc., TX). Mutations in GLYT1b were generated using the QuikChange site-directed mutagenesis kit from Stratagene, and all mutations were confirmed by DNA sequencing.
Oocytes were harvested from X. laevis as previously described (32) , and 50 nl of cRNA was injected into defolliculated, stage V oocytes and incubated at 16°C in standard frog Ringer's solution (ND96; 96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 5 mM HEPES, pH 7.55), supplemented with 2.5 mM sodium pyruvate, 0.5 mM theophylline, 50 g/ml gentamycin. 2-5 days later, current recordings were made at Ϫ60 mV using the 2-electrode voltage clamp technique with a Geneclamp 500 amplifier (Axon Instruments, Foster City, CA) interfaced with a MacLab 2e chart recorder (ADI Instruments, Sydney, Australia) using Chart software (ADI Instruments). Recordings were made using the standard frog Ringer's solution, and, in experiments investigating the effects of pH, the pH of the bath solution was adjusted with HCl and NaOH.
[ , was applied for 1 min with constant flow followed by a 2-min washout. The oocyte was then removed from the recording chamber and lysed in 50 mM NaOH, and scintillation counting was performed. Estimates of the net charge generated by 30 
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Zn
2ϩ Modulation of Glycine Transport-Glycine transport by GLYT1 and GLYT2 is coupled to 2 and 3 Na ϩ ions, respectively and 1 Cl Ϫ ion (17, 34) , resulting in a net transfer of one positive charge with each glycine molecule for GLYT1 and two positive charges for GLYT2. Application of glycine to oocytes expressing the human glycine transporters, GLYT1b or GLYT2a, voltage-clamped at Ϫ60 mV, generates dose-dependent inward currents. Co-application of 100 M Zn 2ϩ with 30 M glycine significantly reduced the GLYT1b transport current but had no effect on GLYT2a (Fig. 1) . The onset of inhibition by Zn 2ϩ in GLYT1b was rapid and reversible with washout of Zn 2ϩ from the bath solution, which indicates a direct interaction of Zn 2ϩ with the transporter. Dose-dependent GLYT1b transport currents were measured in the absence and presence of 100 M Zn 2ϩ . Under these conditions, 100 M Zn 2ϩ reduced the maximal glycine transport current by 42 Ϯ 2% (n ϭ 5) with no significant change in the EC 50 for glycine (18 Ϯ 3 versus 21 Ϯ 4 M, n ϭ 5) ( Fig. 2A ; Table I ). This suggests that Zn 2ϩ is acting as a noncompetitive inhibitor of GLYT1b. Inhibition of GLYT1b transport currents by Zn 2ϩ is dose-dependent with an IC 50 value of 9.7 Ϯ 1.9 M (n ϭ 8) and maximal inhibition of 47 Ϯ 4% (n ϭ 8) (Fig. 2B ). In contrast, application of up to 1 mM Zn 2ϩ to oocytes expressing GLYT2a had no effect on glycine transport currents (Fig. 2B) .
In other closely related neurotransmitter transporters, such as DAT and GAT, application of substrate activates an uncoupled ion conductance (35, 36) . Therefore, we investigated whether the effects of Zn 2ϩ on GLYT1 can be solely attributed to a reduction in the rate of glycine uptake rather than alteration of an uncoupled conductance state. This was carried out in two separate experiments. First, [ 3 H]glycine uptake in oocytes expressing GLYT1b was measured. In parallel to observations from electrophysiological studies, Zn 2ϩ potently inhibited [ 3 H]glycine uptake with an IC 50 value of 11 M and a maximal inhibition of 52% ( Fig. 5B ; Table II ). Second, [ 3 H]glycine uptake was performed under voltage clamp conditions to obtain measures of charge-to-flux ratios. 30 M [ 3 H]glycine was applied to oocytes voltage-clamped at Ϫ60 mV in frog Ringer's solution with and without 100 M Zn 2ϩ for 1 min. In the presence of 100 M Zn 2ϩ , the glycine transport currents and the rate of [ 3 H]glycine uptake were significantly reduced by 49 Ϯ 6% (n ϭ 6) and 45 Ϯ 4% (n ϭ 6), respectively, compared with that obtained in the absence of Zn 2ϩ (Fig. 3) . The charge-to-flux ratio in the presence of Zn 2ϩ (1.24 Ϯ 0.04; n ϭ 6) was not significantly different from the value obtained in the absence of Zn 2ϩ (1.18 Ϯ 0.08; n ϭ 6) ( Fig. 3) , which indicates that Zn 2ϩ inhibits glycine transport currents by reducing the rate of glycine transport through GLYT1b. The charge-to-flux ratios obtained are also consistent with the stoichiometry of 2 Na ϩ :1 Cl Ϫ :1 glycine for GLYT1b (17, 20, 34) . We have also examined the ability of other divalent cations, Cd 2ϩ and Ni 2ϩ , to inhibit glycine transport currents by GLYT1b. Ni 2ϩ potently inhibited glycine transport currents with the IC 50 value (8.2 Ϯ 1.0 M, n ϭ 4) and the maximal inhibition value (39 Ϯ 4%, n ϭ 4) similar to that of Zn 2ϩ , whereas application of up to 100 M Cd 2ϩ had no effect on GLYT1b transport currents.
Identification of the Zn 2ϩ -binding Residues of GLYT1b-In the following experiments, we employed site-directed mutagenesis to identify amino acid residues that may form the Zn 2ϩ binding site on GLYT1b and also explain the differential Zn 2ϩ sensitivity of GLYT1b compared with GLYT2a. Histidines, cysteines, glutamates, and aspartates are generally found as coordinating residues in Zn 2ϩ binding sites (37) . The high affinity Zn 2ϩ binding site in the human dopamine transporter (hDAT), another member of the Na ϩ /Cl Ϫ -dependent neurotransmitter transporter family, was mapped to 3 coordinating residues situated on the extracellular face of the transporter (Fig. 4) (38, 39) . Based on the homology between GLYT1b and DAT, we targeted histidine residues and a select number of glutamate residues, which are predicted to be on the extracellular domains of GLYT1b and in similar locations to the Zn 2ϩ -binding residues of DAT.
Histidine residues at positions 199, 239, 243, 410, 421, and 588 of GLYT1b were mutated individually to alanine, and histidine 213 was mutated to proline because a proline residue is found at this position in the closely related GLYT2 subtype of glycine transporters. Application of glycine to oocytes expressing the GLYT1b mutants H199A, H213P, H239A, H243A, H410A, H421A, and H588A generated dose-dependent transport currents of similar magnitude with EC 50 values similar to that of wild type GLYT1b ( (Table I ). In contrast, mutations of His-243 and His-410 markedly impaired the sensitivity to Zn 2ϩ (Fig.  5A) . Mutation of His-243, which lies in the second extracellular loop (ECL2) between TM3 and TM4, caused a 24-fold increase in the IC 50 value for Zn 2ϩ to 237 Ϯ 78 M (n ϭ 3) with a maximal inhibition of 31 Ϯ 6% (n ϭ 3) ( Fig. 5A ; Table I Fig. 3 indicate that the charge-to-flux ratios for both transporters is ϳ1 both in the absence and in the presence of Zn 2ϩ , which is same as wild type GLYT1b. Therefore, the glycine-induced current is tightly coupled to glycine uptake both in the presence and absence of Zn 2ϩ in these mutant transporters.
Glutamate 432 is located at the extracellular end of TM8 of GLYT1b and is conserved in GLYT1, hDAT, hNET (the human norepinephrine transporter), and GAT (Fig. 4) . In DAT, it has been shown that the equivalent glutamate residue is involved in forming the Zn 2ϩ coordination site and, furthermore, substitution of this glutamate residue with a histidine residue allowed Zn 2ϩ to more effectively inhibit dopamine uptake by hDAT (39 (Tables I and II) , which demonstrates that the mutations do not disrupt the transport process. The E432Q mutation did not significantly affect the Zn 2ϩ sensitivity of glycine transport currents or [ 3 H]glycine uptake, whereas the E432H mutation resulted in a small but significantly lower IC 50 value for Zn 2ϩ inhibition of glycine currents and [
3 H]glycine uptake compared with both wild type GLYT1b and the E432Q mutant (Tables I and II) . Both mutations caused a slight decrease in the maximal inhi- (Tables I and II) . The small effects on the IC 50 for Zn 2ϩ and on the % maximal inhibition caused by mutations at Glu-432 suggest that this glutamate residue may play a minor role in the formation of the Zn 2ϩ binding site, but is unlikely to directly form the coordination site for Zn 2ϩ on GLYT1b.
Three cysteine residues are located on extracellular loops of GLYT1b. It has previously been shown that application of the membrane impermeant sulfhydryl reagent MTSET to oocytes expressing GLYT1b led to an inhibition of glycine transport via an interaction with cysteine 116, which is located in ECL1 of GLYT1b (40) . Therefore, Cys-116 was examined in our study for potential Zn 2ϩ coordination. The C116A mutant exhibited similar EC 50 value for glycine transport currents and IC 50 value for Zn 2ϩ inhibition of transport currents as wild type GLYT1b (Table I) . Thus, the C116A mutation does not appear to alter the functional property of the transporter or the sensitivity to Zn 2ϩ , indicating that Cys-116 is unlikely to form part of the Zn 2ϩ binding site on GLYT1b. In addition, application of 1 mM MTSET for 5 min to oocytes expressing the wild type GLYT1b transporter decreased the glycine transport currents by 44 Ϯ 2% (n ϭ 6), which is consistent with the previous finding (40) . Application of 100 M Zn 2ϩ after MTSET treatment of wild type GLYT1b caused reductions in the glycine currents similar to those observed before MTSET treatment (43 Ϯ 0.2% versus 43 Ϯ 1%, n ϭ 3). Thus, MTSET modification of GLYT1b does not influence the sensitivity to Zn 2ϩ , further indicating that cysteine residues are not involved in Zn 2ϩ coordination of GLYT1b.
Mutation of His-410 Abolishes the Proton Sensitivity of GLYT1b-It has previously been shown that protons noncompetitively inhibit glycine transport by GLYT1b and mutation of His-421, in ECL4 of GLYT1b, renders the transporter insensitive to regulation by pH (20) . Because the Zn 2ϩ -binding residue, His-410, is located in the same extracellular domain as the proton regulatory site, we tested the pH sensitivity of GLYT1b-H410A. We also mutated the charged residues Asp-414 and Asp-420 to alanine to investigate whether these 2 residues in ECL4 of GLYT1b affect the pH sensitivity. Application of glycine to oocytes expressing the GLYT1b mutants H410A, D414A, D420A, and H421A generated inward currents of similar magnitude to wild type GLYT1b. Glycine (30 M) transport currents were measured at pH levels varying from 5.0 to 8.0 for both the wild type and mutated GLYT1b transporters (Fig. 6) . The pH at which glycine transport by GLYT1b was half-maximal was 6.6 Ϯ 0.1 (n ϭ 4) with a maximal inhibition of 65 Ϯ 4% (n ϭ 4), which is similar with the previous reported value (20) and within the range of reported pH values for the titration of histidine residues. Mutation of His-421 to alanine removed the pH sensitivity of GLYT1b (Fig. 6) , which is consistent with previous findings (20) . Mutation of the neighboring residue Asp-420 caused a modest reduction in pH sensitivity (halfmaximal inhibition at pH 5.9 Ϯ 0.1, n ϭ 4) (Fig. 6) , which is still within the range of sensitivities for titration of histidine residues. Thus, this modest effect is likely to be because of a change in the pK a of the neighboring histidine residue. The D414A mutant displayed a proton inhibition curve indistinguishable from that of wild type GLYT1b, but surprisingly, the H410A mutation substantially reduced the pH sensitivity of GLYT1b, with no significant inhibition of the glycine transport currents observed until pH 5.5 (Fig. 6) . Thus, mutation of His-410 impairs both the Zn 2ϩ sensitivity and the proton sensitivity of GLYT1b. In contrast, mutation of His-243, another Zn 2ϩ -coordinating residue of GLYT1b, to alanine, retained the wild type pH sensitivity (Fig. 6 ). (Fig. 7) . Application of glycine to oocytes expressing the C116A/H243C and C116A/H410C double mutants generated currents of similar magnitude with EC 50 values similar to both the C116A mutant and wild type GLYT1 (Table I) , which demonstrates that the transporter functions of the double mutants are not significantly altered compared with the wild type transporter. Co-application of increasing doses of Zn 2ϩ with a fixed dose of glycine to the C116A/H243C mutant resulted in inhibition of the transport currents (Fig. 7E) . Although the potency of Zn 2ϩ inhibition was similar to wild type, the maximal reduction in transport currents was only 18 Ϯ 2% (n ϭ 4) for this double mutant, in contrast to ϳ50% for the C116A and the wild type transporter (Table I) (Fig. 7, D and E) . This indicates that the H243C mutant retains Zn 2ϩ affinity, but the consequences of Zn 2ϩ binding are not as pronounced as in the wild type transporter. After application of the positively charged MTSET re- 
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agent, glycine transport currents of H243C were unaffected, but its sensitivity to Zn 2ϩ was markedly reduced (Fig. 7, B and  E) . Thus, H243C appears to be accessible to the MTSET reagent, but introduction of a positive charge at this site (via MTSET) does not result in similar reductions in glycine transport currents as observed for Zn 2ϩ binding to the wild type GLYT1 and the C116A mutant. Considerably different results were obtained with the C116A/H410C double mutant. Application of Zn 2ϩ at concentrations up to 300 M to oocytes expressing the C116A/H410C mutant had no effect on glycine transport currents (Fig. 7F) . Treatment with MTSET caused a 20 Ϯ 2% (n ϭ 3) reduction in the maximal glycine transport current, and subsequent application of Zn 2ϩ did not further inhibit transport currents, but in fact caused a small increase in transport currents (Fig. 7, C and F) . Thus, H410C is accessible to the MTSET reagent but renders the transporter insensitive to Zn 2ϩ . To investigate whether the positive charge introduced by the MTSET reagent was responsible for the inhibitory effect on glycine transport currents, we compared the effects of MTSET with that of the negatively charged MTSES reagent. Treatment of C116A/H410C with MTSES caused a similar reduction in glycine transport currents as observed after MTSET treatment (21 Ϯ 2%, n ϭ 3), and subsequent application of Zn 2ϩ had no further inhibitory effect. Given that introduction of a negative charge at H410C yields the same effect as a positive charge, the inhibition of glycine transport by MTSET in the H410C mutant cannot result solely from the introduction of a positive charge to this region. Taking this data into account, we conclude that Zn 2ϩ binding to GLYT1 is coordinated by both His-243 and His-410 and propose that Zn 2ϩ binding may generate conformational changes that bring ECL2 and ECL4 into closer proximity, which restricts conformational changes required for transport.
The Effects of Zn 2ϩ and Protons on GLYT2 Mutants-The amino acid residues in GLYT2a at the positions corresponding to His-243 and His-410 of GLYT1b are Ala-363 and Glu-530, respectively (Fig. 4) , and we tested the hypothesis that the presence or absence of these histidine residues determines the differential Zn 2ϩ sensitivity of GLYT1b compared with GLYT2a. We introduced 2 histidine residues into GLYT2a at positions 363 and 530 in place of alanine and glutamate. The GLYT2a-A363H,E530H double mutant was functional and displayed an EC 50 value for glycine transport currents similar to wild type GLYT2a (Table I) . However, the mutant was insensitive to Zn 2ϩ at micromolar concentrations; therefore, it is unlikely to generate a Zn 2ϩ binding site in GLYT2a similar to the site in GLYT1b by exchange of homologous amino acids.
We also examined the proton sensitivity of wild type GLYT2a and found that glycine transport currents by GLYT2a were insensitive to proton titration within the pH range from 8.5 to 5.5 (Fig. 6) . In addition, we tested the proton sensitivity of the GLYT2a-A363H,E530H mutant and found that this transporter was also insensitive to proton titration within the pH range from 8.5 to 5.5 (data not shown). Therefore, protons differentially modulate GLYT1 and GLYT2 and the introduction of a histidine residue in ECL4 of GLYT2a, at the position homologous to His-410 of GLYT1b, does not result in proton sensitivity.
DISCUSSION
This study has demonstrated that Zn 2ϩ is a noncompetitive, partial inhibitor of glycine transport by GLYT1 and has no effect on glycine transport by GLYT2. Zn 2ϩ binding to GLYT1 inhibits the maximal glycine transport current without altering the EC 50 value for glycine (Fig. 2) , and the reduction in transport currents caused by Zn 2ϩ directly correlates with a reduction in the rate of glycine transport (Fig. 3) . These results Table II .
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suggest that Zn 2ϩ inhibits glycine transport by specifically inhibiting the translocation process without affecting glycine binding or altering the ion-flux coupling of glycine transport. Thus, Zn 2ϩ may be thought of as an allosteric regulator of GLYT1.
Molecular Basis for Zn 2ϩ Modulation of GLYT1b-To attain a better understanding of the structural basis for the mechanism of action of Zn 2ϩ on glycine transporters, we characterized the Zn 2ϩ binding site on GLYT1b using a site-directed mutagenesis strategy. We identified 2 histidine residues on the extracellular face of GLYT1b, which, when mutated, greatly reduced Zn 2ϩ affinity without affecting glycine binding, suggesting that these residues may represent, at least in part, the molecular determinants for Zn 2ϩ inhibition. The mutation of His-243 to alanine in ECL2 markedly decreased the potency of Zn 2ϩ inhibition of glycine transport currents and the potency of Zn 2ϩ inhibition of [ 3 H]glycine uptake by ϳ24-and ϳ17-fold, respectively, whereas the mutation of His-410 to alanine in ECL4 completely eliminated the inhibitory effect of Zn 2ϩ on GLYT1b ( Fig. 5 ; Tables I and II) . X-ray crystallographic studies 
of Zn 2ϩ -binding proteins have demonstrated that the imidazole groups of histidine residues interact directly with Zn 2ϩ (37) and that there is a crude correlation between the affinity of Zn 2ϩ and the number of coordinating residues (41) . The affinity of Zn 2ϩ for binding sites involving 2 histidine residues is predicted to range from 10 to 100 M, whereas for 3 coordinating residues affinities are in the range of 0.01-1 M. From the IC 50 values of 9.7 and 11 M for Zn 2ϩ inhibition of transport currents and [
3 H]glycine uptake, respectively, it is most likely that a single Zn 2ϩ ion binds to 2 histidine residues. However, as the IC 50 is at the lower end of the range for coordinating 2 histidine residues, the question arises as to whether any other amino acid residues also contribute to the formation of the Zn 2ϩ binding site. The H410A mutation caused a complete loss of Zn 2ϩ sensitivity, but the H243A mutation caused a 24-fold reduction in Zn 2ϩ affinity to 237 M for Zn 2ϩ inhibition of transport currents and a 17-fold reduction in Zn 2ϩ affinity to 184 M for Zn 2ϩ inhibition of [ 3 H]glycine uptake. These concentrations required for Zn 2ϩ inhibition of H243A are at the upper limit for affinities of Zn 2ϩ binding sites involving 2 residues. Thus, there are two possibilities for the interaction of Zn 2ϩ with the H243A mutant. The first is that Zn 2ϩ binding to H243A is mediated by the remaining coordinating residue, His-410, and that other residues play only a minor role in the binding process but do not directly bind the Zn 2ϩ ion. The second option is that there is an additional coordinating residue, which, when combined with the remaining His-410 residue, forms a low affinity binding site for Zn 2ϩ . In an effort to search for additional residues that may also play a role in Zn 2ϩ binding to GLYT1b, we targeted other residues such as Glu-432 at the extracellular edge of TM8. However, the E432Q mutation did not cause any appreciable effects on the IC 50 value for Zn 2ϩ inhibition of transport (Tables I and II ), indicating that Glu-432 is unlikely to form a direct contact with Zn 2ϩ . It is interesting to note that the E432H mutation resulted in a small increase in Zn 2ϩ affinity compared with wild type (Tables I and  II) , and therefore it is possible that, although this residue is unlikely to directly interact with Zn 2ϩ , it may contribute indirectly to the formation of the Zn 2ϩ binding site. We have not identified any other residues that are likely to be directly involved in Zn 2ϩ binding, and we tentatively conclude that His-243 and His-410 are likely to represent the major determinants of the Zn 2ϩ coordination site. From crystal structures of Zn 2ϩ -binding proteins, it is known that the distance between the Zn 2ϩ ion and the coordinating nitrogen of a histidine residue averages 2 Å (42). Thus, the identification of 2 histidines, His-243 in ECL2 and His-410 in ECL4, as two coordinates in the Zn 2ϩ binding site of GLYT1b imposes an important distance constraint in the tertiary structure of GLYT1b. Although the 2 residues are distant in the primary structure, their common participation in binding of the small Zn 2ϩ ion defines their spatial proximity and the close association between ECL2 and ECL4 in the tertiary structure of the transporter.
It has previously been shown that protons inhibit glycine transport by GLYT1b in a noncompetitive manner with a maximal inhibition of ϳ60% (20) . Therefore, protons act in a manner analogous to that of Zn 2ϩ on GLYT1b and proton modulation shares functional features with Zn 2ϩ modulation of GLYT1b. Our study shows that mutating His-410 within ECL4 of GLYT1b, which abolishes the Zn 2ϩ sensitivity, also disrupts the proton modulation (Figs. 5 and 6 ), whereas mutating His-421 within ECL4 of GLYT1b removes the proton sensitivity (20) but increases the apparent affinity for Zn 2ϩ by 3-fold ( Fig.  6 and Table I ). Thus, His-410 is critical for both Zn 2ϩ regulation and proton regulation of GLYT1b and the Zn 2ϩ binding site is in close association with the proton binding site on GLYT1b. In contrast, mutating His-243, the other Zn 2ϩ coordinate of GLYT1b, does not affect the proton sensitivity. Thus, the molecular determinants of proton regulation of GLYT1b are localized to the 2 histidine residues (His-410 and His-421) of ECL4, suggesting that ECL4 contains molecular entities that regulate transporter function in a pH-sensitive manner. The ability of Zn 2ϩ and protons to regulate the rate of glycine transport by interacting with residues situated in ECL4 of GLYT1b indicates that this region may play an important role in the substrate translocation mechanism. The observation that both Zn 2ϩ and H ϩ bind to His-410 and reduce the rate of glycine transport prompts the question as to what is the mechanism underlying the inhibitory effects of these ions. We attempted to distinguish between two possible explanations, which are 1) that Zn 2ϩ or H ϩ binding may serve to introduce a positive charge into the vicinity of His-243 or His-410, which may influence the rate of transport; and 2) that Zn 2ϩ binding to His-243 and His-410 serves to bring the second and fourth extracellular loops into closer proximity and restrains the relative motion between these loops, which may be critical for the transport process. The results of experiments with MTS reagents and the cysteine mutants of His-243 and His-410 do not support the first explanation. Although introduction of a positive charge to H410C, via the MTSET reagent, does reduce the rate of glycine transport by 20%, similar effects were also observed using the negatively charged MTSES reagent; therefore, despite a common interaction of Zn 2ϩ and protons with His-410, introduction of the positive charge per se cannot explain the inhibitory effects on glycine transport. Although it is not possible to be definitive in interpreting the functional consequences of mutagenesis data, it would appear that the second explanation presented above is more likely to account for Zn 2ϩ inhibition of GLYT1.
An important function of the TM7/TM8 region in Na ϩ /Cl Ϫ -dependent neurotransmitter transporters has also been indicated from recent studies in the SERT (43, 44) . ECL4, connecting TM7 and TM8, was suggested to play a role in substrate translocation of SERT (43) ; in addition, TM7 of SERT has been suggested to be involved in propagating conformational changes caused by ion binding, perhaps as part of the translocation mechanism (44) . Thus, it is conceivable that Zn 2ϩ or proton binding to GLYT1b may alter the conformation of ECL4 and subsequently transmit this change to the two adjoined transmembrane domains, TM7 and TM8, to regulate the rate of substrate transport.
Comparisons of the Zn 2ϩ Binding Site on GLYT1b with Other Na ϩ /Cl Ϫ -dependent Neurotransmitter Transporters-Alignment of the amino acid sequences of GLYT2a with GLYT1b shows that the Zn 2ϩ -coordinating histidine residues of GLYT1b are not conserved in GLYT2a (Fig. 4) , thus it seems likely that these 2 histidines determines the differential Zn 2ϩ sensitivity between glycine transporter subtypes. However, introducing these residues at the homologous positions in GLYT2a failed to produce Zn 2ϩ sensitivity, suggesting that the formation of the Zn 2ϩ binding site requires precise three-dimensional positioning of the 2 histidine residues and that the 2 glycine transporter subtypes may display distinct tertiary structures.
Three amino acid residues were identified as coordinating ligands in the endogenous Zn 2ϩ binding site of hDAT: His-193 in the second extracellular loop between TM3 and TM4, His-375 at the external end of TM7, and Glu-396 at the external end of TM8 (Fig. 4) (38, 39) . A simple exchange of homologous amino acids resulted in the transfer of the high affinity Zn 2ϩ -binding property from hDAT to hNET (38, 39) and the rat GABA transporter-1 (rGAT-1) (45), which are otherwise Zn 2ϩ -
insensitive, providing support for a conserved structural organization of the TM7/TM8 domain between hDAT, hNET, and GAT-1. The 2 histidines involved in Zn 2ϩ binding to hDAT are in similar locations as the 2 Zn 2ϩ -coordinating histidine residues of GLYT1b. However, the third Zn 2ϩ coordinate of hDATGlu-396, which is also conserved in GLYT1, hNET, and GAT-1 and is involved in forming the Zn 2ϩ binding sites of hNET and GAT-1, is not likely to participate in Zn 2ϩ coordination of GLYT1b, based on the observation that mutating the homologous glutamate at the external end of GLYT1b did not impair the Zn 2ϩ binding property (Tables I and II) . Therefore, the Zn 2ϩ binding site of GLYT1b is unlikely to be identical to that of hDAT. Another interesting difference between hDAT and GLYT1 is that Zn 2ϩ binding to hDAT has a more marked inhibitory effect (100 M Zn 2ϩ inhibits dopamine uptake by 70% (Refs. 38 and 39)), whereas in GLYT1 a maximal dose of Zn 2ϩ causes only a ϳ50% reduction in glycine transport. A possible explanation for these differences in efficacy is that Zn 2ϩ is bound to GLYT1 with only 2 coordinating residues, which may impose less structural constraints in conformational changes associated with substrate transport compared with 3 coordinating residues for Zn 2ϩ binding to hDAT. The IC 50 values for Zn 2ϩ inhibition of glycine transport currents and for Zn 2ϩ inhibition of [ 3 H]glycine uptake are 9.7 and 11 M, respectively, which are within the predicted concentration range of the free extracellular Zn 2ϩ in the brain (21) (22) (23) ). This result is suggestive that GLYT1b could represent a sensitive target for synaptically released Zn 2ϩ and Zn 2ϩ modulation of GLYT1b may have important physiological and pathological implications. It has recently been demonstrated that glycine concentrations within excitatory synapses are not sufficient to saturate the glycine binding site of NMDA receptors and GLYT1 may efficiently control glycine modulation of NMDA receptor function (46, 47) . Therefore, it would be interesting to investigate whether regulation of the GLYT1 transporter activity by Zn 2ϩ and protons does play an important role in shaping the dynamics of NMDA receptor-mediated excitatory neurotransmission.
